<DOC>
	<DOCNO>NCT02244385</DOCNO>
	<brief_summary>25-30 % woman preexist vascular disease ( chronic hypertension/diabetes/obesity ) develop pre-eclampsia growth restriction . In addition , frequency stillbirth group dramatically increase general population . Pregnancy complication heterogeneous group likely combination failure maternal vasculature adapt pregnancy and/or failure placental development . The relative contribution two mechanism poorly understood current preventative strategy ( aspirin ) group prevent small number adverse outcomes . This important complex group inadequately investigated date mainly diversity underlying disease complicate prospective research study . The evolution tool allow detailed assessment uteroplacental blood flow maternal vascular function enable u perform prospective study woman develop targeted preventative measure . Recent biomarker study also identify number biomarkers yet assess high risk group .</brief_summary>
	<brief_title>Manchester Antenatal Vascular Service</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>Women preexist vascular disease : 1. chronic hypertension BP ≥140/90 ≤14 week 2. chronic hypertension require antihypertensive treatment ≤ 14 week 3. pre gestational diabetes evidence vascular complication ( hypertension , nephropathy ) 4. history ischemic heart disease 5. previous early onset preeclampsia ( delivery &lt; 32 week ) 6 . Obesity ( BMI ≥ 40 ) history hypertension book BP≥130/80 Women meet inclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>vascular disease</keyword>
	<keyword>pregnancy</keyword>
	<keyword>chronic hypertension</keyword>
	<keyword>diabetes</keyword>
	<keyword>obesity</keyword>
</DOC>